Uterine serous papillary adenocarcinoma cell lines grown as primary cultures were tested by qRT–PCR to confirm at mRNA level the different HER2/neu surface receptor expressions. The gene discussed is ERBB2; the disease is endometrial serous adenocarcinoma.